Literature DB >> 6134622

Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.

K A Jönsson, G Bodemar, R Gotthard, B Norlander, A Walan.   

Abstract

The plasma concentration curves and urinary excretion of oxmetidine after administration of single i.v. (100 mg) and oral (200 mg) doses have been studied in 11 patients with peptic ulcer disease. The mean bioavailability of the drug was 70% (range 53-91%). After intravenous administration, the mean plasma t 1/2 beta was 3.0 h, the mean apparent volume of distribution 0.7 l/kg, the mean total plasma clearance 12.3 l/h and the mean plasma renal clearance was 0.7 l/h. Following intravenous and oral administration an average of 6% and 3%, respectively, of unchanged drug was found in the urine. The plasma concentration curve after oral administration in most patients exhibited two maxima, with peak concentrations appearing between 45 and 210 min after dosing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134622     DOI: 10.1007/bf00610054

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease.

Authors:  G Bodemar; B Norlander; L Fransson; A Walan
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

2.  Pharmacokinetics of cimetidine after single doses and during continuous treatment.

Authors:  G Bodemar; B Norlander; A Walan
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

3.  Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.

Authors:  J G Mills; P L Brunet; R Griffiths; R H Hunt; D Vincent; G J Milton-Thompson; W L Burland
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

4.  Prolactin responses to histamine H2 receptor antagonists.

Authors:  P C Sharpe; M A Melvin; J G Mills; W L Burland; G V Groom
Journal:  Acta Endocrinol (Copenh)       Date:  1980-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.